Ming, Simon Wan YauHaughney, JohnSmall, IainWolfe, StephanieHamill, JohnGruffydd-Jones, KevinDaly, CathalSoriano, Joan BGardener, ElizabethSkinner, Derekd'Alcontres, Martina StagnoPrice, David B.2018-06-242018-06-242017-08Ming, S W Y, Haughney, J, Small, I, Wolfe, S, Hamill, J, Gruffydd-Jones, K, Daly, C, Soriano, J B, Gardener, E, Skinner, D, d'Alcontres, M S & Price, D B 2017, 'Initiating or changing to a fixed-dose combination of fluticasone propionate/formoterol over fluticasone propionate/salmeterol : a real-life effectiveness and cost impact evaluation', Respiratory Medicine, vol. 129, pp. 199-206. https://doi.org/10.1016/j.rmed.2017.06.0160954-6111http://hdl.handle.net/2164/10654With institutional support from NAPP Pharmaceutical Group Ltd. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work and have given final approval to the version to be published. The authors would like to thank Rosalind Bonomally for medical writing support.8142073engAsthmaCost-effectivenessFixed-dose combination inhalersFormoterolGINAReal-lifeR Medicine (General)R1Journal article10.1016/j.rmed.2017.06.016129